Shimadzu (7701 JP): Conservative Guidance
Down 13.5% from its recent high despite beating guidance for last FY and low-balling this FY. Healthcare and semiconductor demand remain strong....
218 Views
Shimadzu (7701 JP): Buy into the Sell-Off
The shares have dropped 14% from an all-time high reached on Feb 22, while sales have recovered from the COVID downturn and profit margins are...
259 Views
Shimadzu (7701 JP): Virus Defeated in 1Q
After guiding for a 12% decline in sales and a 47% decline in operating profit in FY Mar-21 as a whole, Shimadzu delivered a 1% year-on-year...
251 Views
🇯🇵 JAPAN • Results & Revisions 20th May - Shimadzu, Amada, Funai Soken, Kobe Bussan
Shimadzu (7701 JP) In the DETAIL below, we shall review yesterday's announcements:- The balance between positive/neutral/negative of the 771...
107 Views
Terumo: Not Just an Opportune COVID Play but a Business with Solid Long-Term Prospects
Terumo Corp (4543 JP) provides innovative medical solutions through its extensive business portfolio which ranges from vascular intervention and...
278 Views